Inhibition of hepatitis B virus X gene expression by novel DNA enzymes

Biochemical Journal

Volumn 353, Issue 3, 2001, Pages 701-708

  Goila, R ^a   Banerjea, A C ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

Gene cleavage; Gene silencing; Gene therapy

Indexed keywords

ENZYME; MAGNESIUM ION;

ANIMAL CELL; ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME SPECIFICITY; GENE EXPRESSION REGULATION; GENE SILENCING; GENE THERAPY; HEPATITIS B VIRUS; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REPORTER GENE; VIRUS GENE;

ANIMALS; BASE SEQUENCE; CELL LINE; COS CELLS; DEOXYRIBONUCLEASES; DNA PRIMERS; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HIV LONG TERMINAL REPEAT; HUMANS; KINETICS; PROMOTER REGIONS (GENETICS); TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS;

ANIMALIA; DNA VIRUSES; HEPATITIS B VIRUS; MAMMALIA;

EID: 0035253125     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3530701     Document Type: Article

References (29)

1. The chemistry of self splicing RNA and RNA enzymes
2. A small catalytic oligoribonucleotide
3. Simple RNA enzymes with new and highly specific endoribonuclease activities
4. Controlled, targeted, intracellular expression of ribozymes: Progress and problems
5. The potential of ribozymes as antiviral agents
6. Anti gene therapy: The use of ribozymes to inhibit gene function
7. Functional characterization of a U5 ribozyme: Intracellular suppression of human immunodeficiency virus type 1 expression
8. Multitarget-ribozymes directed to cleave up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication - Potential effectiveness against most presently sequenced HIV-1 isolates
9. Inhibition of replication of HIV-1 by retroviral vectors expressing tat-antisense and anti-tat ribozyme RNA
10. Ribozymes as potential anti-HIV-1 therapeutic agents
11. Development of HIV vectors for anti HIV gene therapy
12. A chimeric human immunodeficiency virus type 1 (HIV-1) minimal Rev response element-ribozyme molecule exhibits dual antiviral function and inhibits cell-cell transmission of HIV-1
13. Defective HIV-1 provirus encoding a multitarget ribozyme inhibits accumulation of spliced and unspliced HIV-1 mRNAs, reduces infectivity of viral progeny and protects the cells from pathogenesis
14. A comparison of the in vitro activity of DNA-armed and all-RNA hammerhead ribozymes
15. Nuclease-resistant ribozymes decrease stromelysin mRNA levels in rabbit synovium following exogenous delivery to the knee joint
16. In vivo studies with antisense oligonucleotides
17. A general purpose RNA cleaving DNA enzyme
18. Sequence specific cleavage of HIV-1 coreceptor CCR5 gene by a hammer-head ribozyme and a DNA-enzyme: Inhibition of coreceptor function by DNA-enzyme
19. Targeted cleavage of HIV-1 envelope gene by a DNA enzyme and inhibition of HIV-1 envelope-CD4 mediated cell fusion
20. The hepatitis B virus X gene: Analysis of functional domain variation and gene phylogeny using multiple sequences
21. Hepatitis B virus X-gene product: A promiscuous transcriptional activator
22. The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors
23. A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function
24. Hepatitis B virus X gene can transactivate heterologous viral sequences
25. Reovirus protein sigma 1 translated in vitro as well as truncated derivatives of it that lack up to two thirds of its C terminal portion exists as two major tetrameric species that differ in electrophoretic mobility
26. First report of a healthy Indian heterozygous for Δ 32 mutant of HIV-1 co-receptor-CCR5 gene
27. Specific inhibition of hepatitis C virus expression by antisense oligodeoxynucleotides. In vitro model for selection of target sequence
28. Production of acquired immunodeficiency syndrome associated retrovirus in human and nonhuman cells translected with an infectious molecular clone
29. High-level synthesis of biologically active reovirus protein sigma 1 in a mammalian expression vector system